Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brevium is a private digital health and healthcare software company focused on patient reactivation for medical practices. Its platform integrates with practice management systems to identify patients lost to follow-up, automate multichannel outreach, and bring overdue patients back into care. The company markets its software across numerous ambulatory specialties including ophthalmology, dermatology, allergy, cardiology, OB/GYN, behavioral health, gastroenterology, ENT, pain, urology, optometry, and primary care. Brevium positions its technology as improving patient compliance, filling provider schedules, and increasing practice revenue, rather than developing therapeutics. The company appears to be a commercial-stage healthcare IT vendor rather than a biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brevium.